Free shipping on all orders over $ 500

Thalidomide-O-amido-C8-NH2 TFA

Cat. No. M14861

All AbMole products are for research use only, cannot be used for human consumption.

Thalidomide-O-amido-C8-NH2 TFA Structure
Synonym:

Cereblon Ligand -Linker Conjugates 2 TFA; E3 Ligase Ligand-Linker Conjugates 20 TFA

Size Price Availability Quantity
5mg USD 55 In stock
10mg USD 80 In stock
25mg USD 120 In stock
50mg USD 200 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

Thalidomide-O-amido-C8-NH2 TFA (Cereblon Ligand -Linker Conjugates 2 TFA) is a synthesized E3 ligase ligand-linker conjugate that incorporates the Thalidomide based cereblon ligand and a linker used in PROTAC technology.

Chemical Information
Molecular Weight 572.53
CAS Number 1950635-16-1
Solubility (25°C) DMSO ≥ 131 mg/mL
Storage 2-8°C, dry, sealed
References

[1] Shira Joudan, et al. Insufficient evidence for the existence of natural trifluoroacetic acid

[2] Susana P Alves, et al. Trans-10 18:1 in ruminant meats: A review

[3] Israel Oluwaseyidayo Idris, et al. The evidence of politics in trans-fatty acid regulation in Mexico

[4] Jrme Clerc. Radioiodine therapy of thyroid autonomy

[5] Chaoyang Li, et al. Global Surveillance of trans-Fatty Acids

Related PROTAC Products
CR8

CR8 is a potent and selective inhibitor of cyclin dependent kinase (CDK1, 2, 5, 7, and 9).

ARV-393

ARV-393 is an orally active PROTAC degrader targeting BCL6 for studies related to diffuse large B-cell lymphoma. ARV-393 utilizes the ubiquitin-proteasome system to target the degradation of BCL6.

ARV-766

ARV-766 is an orally active and potent proteolysis targeting chimera (PROTAC) protein degrader. ARV-766 degrades wild-type androgen receptor (AR) but also relevant AR LBD mutants, including the most prevalent AR L702H, H875Y, and T878A mutations. ARV-766 has the potential to be first- and best-in class PROTAC AR degrader in mCRPC.

Indisulam

Indisulam is a carbonic anhydrase inibitor and antitumor CDK inhibitor. Indisulam targets the G1 phase of the cell cycle by depleting cyclin E. inducing p53 and p21, and inhibiting CDK2, causing a blockade in the G1/S transition.

dBET6

dBET6 is a highly potent, selective and cell-permeable PROTAC connected by ligands for Cereblon and BET, with an IC50 of 14 nM, and has antitumor activity.

  Catalog
Abmole Inhibitor Catalog




Keywords: Thalidomide-O-amido-C8-NH2 TFA, Cereblon Ligand -Linker Conjugates 2 TFA; E3 Ligase Ligand-Linker Conjugates 20 TFA supplier, PROTAC, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.